Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
IMNMCompany Name
IMMUNOME INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQIMMUNOME INC - Price to Operating Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
IMNM - P/OCF Historical data
| Date | Market Capitalization | Net Cash Flow - Operations | Price to Operating Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 910.49M | $ -178.68M | 0 |
| 3/31/2025 | $ 690.88M | $ -152.68M | 0 |
| 12/31/2024 | $ 745.17M | $ -110.79M | 0 |
| 9/30/2024 | $ 723.41M | $ -86.19M | 0 |
| 6/30/2024 | $ 759.09M | $ -60.64M | 0 |
| 3/31/2024 | $ 882.74M | $ -42.91M | 0 |
| 12/31/2023 | $ 1.47B | $ -7.57M | 0 |
| 9/30/2023 | $ 365.77M | $ 3.21M | 114.02 |
| 6/30/2023 | $ 85.91M | $ 4.25M | 20.21 |
| 3/31/2023 | $ 65.96M | $ 1.86M | 35.48 |
Key Performance Insights, Last 5 Years
- IMMUNOME INC's latest trailing twelve months (TTM) P/OCF stands at 0.
- Over the past 5 years, IMMUNOME INC's average P/OCF has been 56.57.
- The median P/OCF for IMMUNOME INC during this period was 35.48
- IMMUNOME INC reached its highest P/OCF over the past 5 years at 114.02.
- The lowest P/OCF recorded by IMMUNOME INC in the same timeframe 20.21
Similar metrics to P/OCF:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Free Cash Flow to Operating Cash Flow - [Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Price to Operating Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].Market Cap / CF - Operations
(=) P/OCF P/OCF for IMMUNOME INC is calculated as follows: Market Cap [ $ 120.49M ] / CF - Operations [ $ 0 ]
(=) P/OCF [ 0 ] IMNM - Price to Operating Cash Flow, Last 5 years
20.21
Minimum
Jun 30, 2023
114.02
Maximum
Sep 30, 2023
56.57
Average
35.48
Median
P/OCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/OCF for companies in the Total Stock Market. The average P/OCF of the companies is 13.1 with a standard deviation of 8.81.
The following table provides additional summary stats:
P/OCF in the Market:
| filtered constituents | 2.56K |
|---|---|
| min | 0.08 |
| max | 42.03 |
| average | 13.1 |
| median | 10.77 |
| std | 8.81 |